Signal Transduction and Targeted Therapy figure requirements
-
Column width
- Not specified
-
Font size
- Smallest text
- 8 pt After acceptance
-
Font
- Not specified
-
Resolution
- ≥ 300 dpi
-
File format
- JPEG
-
Color mode
- Not specified
-
Line width
- Thinnest line
- ≥ 0.25 pt After acceptance
Differs from most Springer Nature journals in: Font size, Font, File format, Color mode, Line width
About the journal
- Field
- Immunology, Infectious Diseases
- Topics
- SARS-CoV-2 and COVID-19 Research, Cancer Immunotherapy and Biomarkers, COVID-19 Clinical Research Studies
- Open access
- Yes
- Article charge
- US$3,790
- h-index
- 297
- Articles published
- About 3,060
- Journal website
- nature.com/sigtrans
Journals in the same field
| Journal | Width | Smallest text | Min. resolution |
|---|---|---|---|
| Signal Transduction and Targeted Therapy | Not specified | 8 pt | ≥ 300 dpi |
| Lancet Oncology | 107 mm | Not specified | ≥ 300 dpi |
| Nature Reviews Clinical Oncology | Not specified | Not specified | ≥ 300 dpi |
| Journal of Investigative Dermatology | 87.5–180 mm | Not specified | ≥ 300 dpi |
| British Journal of Dermatology | Not specified | 11 pt | ≥ 300 dpi |
| Nature Reviews Cardiology | Not specified | Not specified | ≥ 300 dpi |
Sources
Checked on 2026-11-04
Check your figure against Signal Transduction and Targeted Therapy’s requirements
Choose a desktop version